Radioimmunoassay Market worth $428.4 Million by 2020


Posted September 27, 2017 by swap123

Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User, Application, and Geography

 
Browse 75 market data Tables and 68 Figures spread through 113 Pages and in-depth TOC on "Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020"
http://www.marketsandmarkets.com/Market-Reports/radioimmunoassay-market-172815697.html
Early buyers will receive 10% customization on reports.

The technique of radioimmunoassay is basically used to measure the concentration of specific antigens by using specific antibodies. This technique is mainly used for research purposes rather than diagnostics purposes. This market constituted 2.3% share of the global immunoassay market.

Radioimmunoassay has applications in the field of clinical diagnostics, and is used in hospitals, contract research organizations (CRO), laboratories, pharmaceutical companies, and others. It is used for the early detection and diagnosis of cancer, recognition of endocrinological disorders, and various other applications. Pharmaceuticals companies use the RIA techniques for medicine and drug testing. Radioimmunoassay also has its application in the research purposes, and this segment contributed a share of 65.9% to the overall market in 2014.

Over the years, there has been a significant growth in the utilization of radioimmunoassay technique in Europe owing to the advancements in medical research, clinical trials, and pharmaceutical industries. Over the next five years, the growth in the Asian radioimmunoassay market is expected to be centered in China, India, and Japan. The European radioimmunoassay market contributed the largest share in the global market, and was valued at $121.5 million in 2014. It is projected to reach $154.6 million by 2020, at a CAGR of 3.9% during the given forecast period. The limitations of the global RIA market are its high cost; government restrictions; and continuous innovations in the biomedical research for other immunoassay techniques, such as enzyme-linked immunosorbent assay (ELISA) kits. Major companies operational in the radioimmunoassay market are DIAsource ImmunoAssays SA (Europe), Immunotec Inc. (Canada), and DIAsource ImmunoAssay S.A.(Europe).

Some of the major players in the global radioimmunoassay market are DIAsource ImmunoAssays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A.. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany).
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Country India
Categories Medical
Tags radioimmunoassay market
Last Updated September 27, 2017